Aureus
FRed Flag

Vertex Pharmaceuticals Incorpor(VRTX)

F

Financial data as of Dec 31, 2024Declining · Healthcare

FCF Margin-8.9%Free Cash Flow / Revenue
Cash Conversion92.0%Operating CF / Net Income
Free Cash Flow-$978.0M
Revenue$11.0B
Net Cash$2.8BCash exceeds debt
Debt / FCFN/AElevated debt burden
Current Ratio2.69Adequate short-term liquidity
YoY FCF Growth-12.5%5 of 5 quarters positive

How This Grade Was Calculated

Base grade from FCF margin, adjusted by financial health factors

BaseF
→
-0.5FCF trend declining (-12.5% YoY)
→
FinalF

Analysis Summary

Strengths

  • Net cash position ($2.8B)
  • Strong liquidity (current ratio: 2.69)

Concerns

  • Negative FCF margin (-8.9%)
  • Significant FCF decline (-12.5% YoY)

Financial Breakdown

Key financials compared side by side

Margin Composition

FCF Margin-8.9%
Net Margin-4.9%
Operating CF Margin-4.5%
CapEx Ratio4.4%

Balance Sheet Health

Debt, liquidity, and leverage snapshot

Net Cash$2.8BCash exceeds debt
Debt / FCFN/AElevated debt burden
Current Ratio2.69Strong liquidity
Debt / Equity0.11Low leverage

Quarterly FCF Trend

-12.5% YoYDeclining (-12.5%)

Free cash flow per quarter

Sector Comparison — Healthcare

FCF Margin ranked against sector peers

View all →

Detailed Metrics

Company NameVertex Pharmaceuticals Incorpor
SectorHealthcare
Free Cash Flow-$978.0M
Revenue$11.0B
Net Income-$535.6M
Operating Cash Flow-$492.6M
Capital Expenditure$485.4M
FCF Margin-8.9%
Cash Conversion Rate92.0%
Net Margin-4.9%
Total Debt$1.7B
Total Cash$4.6B
Net Cash$2.8B
Current Ratio2.69
Debt / Equity0.11
Debt / FCFN/A
YoY FCF Growth-12.5%
Positive Quarters5 of 5
Trend DirectionDeclining
Report DateDec 31, 2024
GradeF
Data SourceYahoo Finance

Related Research

All research →
Sector Report4 min read

Healthcare: Eleven A-Grades and Three Falling Giants

The healthcare sector splits into two groups: companies printing cash and insurers bleeding it. The trend breakdown tells you which side is winning.

Feb 13, 2026
GILDREGNZTSISRG+11